INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
INCYTE CORP
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026
$113.25+0.18 (+0.16%)
Close on Oct 19, 2026
- Market cap
- $23.42B
- P/E (TTM)
- 16.0
- Dividend yield
- –
Share price
+$25.68 (+29.33%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
INCYTE CORP grew revenue 21.5% to $5.36B over the twelve months to Mar 31, 2026. Operating income rose 822.4% to $1.61B, moving the operating margin from 4.0% to 30.0%.
Revenue
$5.36B
+21.5% vs. a year earlier
Operating income
$1.61B
+822.4% vs. a year earlier
EPS, diluted
$7.08
+2522.2% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $23.42B
- P/E ratio
- 16.0
- Price to sales
- 4.37
- Price to book
- 4.17
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $5.36B
- Net income
- $1.43B
- EPS, diluted
- $7.08
- Book value per share
- $27.19
- Diluted shares
- 207M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$5.36B+21.5% YoY
Gross profit
$4.96B+21.2% YoY
Operating income
$1.61B+822.4% YoY
Net income
$1.43B+6631.4% YoY
EPS, diluted
$7.08+2522.2% YoY
Free cash flow
–
Reported periodTrailing twelve months